EGFRvIII upregulates DNA mismatch repair resulting in increased temozolomide sensitivity of MGMT promoter methylated glioblastoma. (2020)

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41388-020-1208-5

PubMed Identifier: 32066879

Publication URI: http://europepmc.org/abstract/MED/32066879

Type: Journal Article/Review

Volume: 39

Parent Publication: Oncogene

Issue: 15

ISSN: 0950-9232